PRAP1 and colorectal cancer: Among these genes we observed CLIC3, PRAP1 and AHNAK2, which have been shown to promote cancer progression of gallbladder carcinoma [25], chemotherapeutic drug resistance in colorectal cancer [26] and epithelial to mesenchymal transition in clear cell renal cell carcinoma [27], respectively.